Home/Filings/4/0001140361-18-024930
4//SEC Filing

Segal Paul 4

Accession 0001140361-18-024930

CIK 0001350653other

Filed

May 20, 8:00 PM ET

Accepted

May 21, 4:32 PM ET

Size

9.4 KB

Accession

0001140361-18-024930

Insider Transaction Report

Form 4
Period: 2018-05-17
Transactions
  • Conversion

    Common Stock

    2018-05-17+7,936,5087,936,508 total
  • Conversion

    Series B Convertible Preferred Stock

    2018-05-1725,0000 total
    Common Stock (7,936,508 underlying)
Footnotes (3)
  • [F1]The Series B Convertible Preferred Stock automatically converted into 7,936,508 shares of Common Stock upon approval by the issuer's stockholders on May 17, 2018.
  • [F2]Each of Jason Hochberg and Evan Bakst serve on the board of directors of the issuer as a representative of the reporting persons. As a result, each reporting person herein may be deemed a director by deputization for the purposes of Section 16 of the Exchange Act.
  • [F3]Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein.

Documents

1 file

Issuer

Alphatec Holdings, Inc.

CIK 0001350653

Entity typeother

Related Parties

1
  • filerCIK 0001427470

Filing Metadata

Form type
4
Filed
May 20, 8:00 PM ET
Accepted
May 21, 4:32 PM ET
Size
9.4 KB